Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Cella

Showing results (201-210 of 1,016) with videos related to

Pageof 102
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 30, 2004
Quality of life of postmenopausal women in the Arimidex, Tamoxifen, Alone or in Combination (ATAC) Adjuvant Breast Cancer TrialLesley Fallowfield, David Cella, Jack Cuzick, et al.
Current Opinion in Organ Transplantation|April 6, 2012
Quality of life, risk assessment, and safety research in liver transplantation: new frontiers in health services and outcomes researchZeeshan Butt, Neehar D Parikh, Anton I Skaro, et al.
Cancer|November 14, 2017
Validity and usefulness of a single-item measure of patient-reported bother from side effects of cancer therapyTimothy P Pearman, Jennifer L Beaumont, Daniel Mroczek, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|July 24, 2008
Estimating clinically meaningful changes for the Functional Assessment of Cancer Therapy--Prostate: results from a clinical trial of patients with metastatic hormone-refractory prostate cancerDavid Cella, Michael B Nichol, David Eton, et al.
Therapy (London, England : 2004)|May 10, 2011
Neuro-QOL and the NIH Toolbox: implications for epilepsyCindy J Nowinski, David Victorson, Jose E Cavazos, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|March 3, 2019
Validity and performance of the Functional Assessment of Cancer Therapy-Bladder (FACT-Bl) among advanced urothelial cancer patientsArnold Degboe, Cristina Ivanescu, Jeffrey M Rohay, et al.
Clinical Lung Cancer|February 20, 2008
Relationship between symptom change, objective tumor measurements, and performance status during chemotherapy for advanced lung cancerDavid Cella, David Eton, Thomas A Hensing, et al.
Cancer|October 13, 2015
Validation of a short questionnaire to measure symptoms and functional limitations associated with hand-foot syndrome and mucositis in patients with metastatic renal cell carcinomaJin-Shei Lai, Jennifer L Beaumont, Jose Diaz, et al.
Health and Quality of Life Outcomes|June 2, 2018
Measurement properties of the Short Form-36 (SF-36) and the Functional Assessment of Cancer Therapy - Anemia (FACT-An) in patients with anemia associated with chronic kidney diseaseFredric O Finkelstein, Floortje van Nooten, Ingela Wiklund, et al.
Cancer|May 24, 2014
Ambulatory cancer and US general population reference values and cutoff scores for the functional assessment of cancer therapyTimothy Pearman, Betina Yanez, John Peipert, et al.
Pageof 102

Showing results (201-210 of 1,016) with videos related to

Sort By:
Pageof 102
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 30, 2004
Quality of life of postmenopausal women in the Arimidex, Tamoxifen, Alone or in Combination (ATAC) Adjuvant Breast Cancer TrialLesley Fallowfield, David Cella, Jack Cuzick, et al.
Current Opinion in Organ Transplantation|April 6, 2012
Quality of life, risk assessment, and safety research in liver transplantation: new frontiers in health services and outcomes researchZeeshan Butt, Neehar D Parikh, Anton I Skaro, et al.
Cancer|November 14, 2017
Validity and usefulness of a single-item measure of patient-reported bother from side effects of cancer therapyTimothy P Pearman, Jennifer L Beaumont, Daniel Mroczek, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|July 24, 2008
Estimating clinically meaningful changes for the Functional Assessment of Cancer Therapy--Prostate: results from a clinical trial of patients with metastatic hormone-refractory prostate cancerDavid Cella, Michael B Nichol, David Eton, et al.
Therapy (London, England : 2004)|May 10, 2011
Neuro-QOL and the NIH Toolbox: implications for epilepsyCindy J Nowinski, David Victorson, Jose E Cavazos, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|March 3, 2019
Validity and performance of the Functional Assessment of Cancer Therapy-Bladder (FACT-Bl) among advanced urothelial cancer patientsArnold Degboe, Cristina Ivanescu, Jeffrey M Rohay, et al.
Clinical Lung Cancer|February 20, 2008
Relationship between symptom change, objective tumor measurements, and performance status during chemotherapy for advanced lung cancerDavid Cella, David Eton, Thomas A Hensing, et al.
Cancer|October 13, 2015
Validation of a short questionnaire to measure symptoms and functional limitations associated with hand-foot syndrome and mucositis in patients with metastatic renal cell carcinomaJin-Shei Lai, Jennifer L Beaumont, Jose Diaz, et al.
Health and Quality of Life Outcomes|June 2, 2018
Measurement properties of the Short Form-36 (SF-36) and the Functional Assessment of Cancer Therapy - Anemia (FACT-An) in patients with anemia associated with chronic kidney diseaseFredric O Finkelstein, Floortje van Nooten, Ingela Wiklund, et al.
Cancer|May 24, 2014
Ambulatory cancer and US general population reference values and cutoff scores for the functional assessment of cancer therapyTimothy Pearman, Betina Yanez, John Peipert, et al.
Pageof 102